Psilocybin and Psychedelics in Maryland: Pending Legislation
This page tracks the current legal status of psilocybin, psychedelics, and entheogens in Maryland. Status is updated from our legislation sync, with citations to the underlying bills and policy decisions.
Maryland is advancing HB 427 and SB 336 in 2026, building on the existing Psilocybin Task Force (established by HB 548 in 2023). The companion bills by Del. Pam Guzzone and Sen. Brian Feldman aim to expand the task force mandate and move toward implementing recommendations for responsible psychedelic use.
HB 427 and SB 336 introduced for the 2026 session by Del. Guzzone and Sen. Feldman Builds on Maryland Task Force on Responsible Use of Natural Psychedelic Substances (HB 548, 2023) Aims to expand task force mandate and implement recommendations Companion bills advancing through respective chambers Maryland positioned as DMV region leader in psychedelic reform Task force has been studying therapeutic potential and regulatory frameworks
Laws change. Always verify current status with primary sources before acting on this information, especially when traveling across state lines.